1 Division of Clinical and Translational Research, Faculty of Medicine and Health, University of Leeds, UK.
2 Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, UK.
Eur Heart J Acute Cardiovasc Care. 2018 Mar;7(2):139-148. doi: 10.1177/2048872616661693. Epub 2016 Aug 29.
Early and accurate diagnosis of acute myocardial infarction is central to successful treatment and improved outcomes. We aimed to investigate the impact of the initial hospital diagnosis on mortality for patients with acute myocardial infarction.
Cohort study using data from the Myocardial Ischaemia National Audit Project of patients discharged with a final diagnosis of ST-elevation myocardial infarction (STEMI, n=221,635) and non-STEMI (NSTEMI, n=342,777) between 1 April 2004 and 31 March 2013 in all acute hospitals ( n = 243) in England and Wales. Overall, 168,534 (29.9%) patients had an initial diagnosis which was not the same as their final diagnosis. After multivariable adjustment, for STEMI a change from an initial diagnosis of NSTEMI (time ratio 0.97, 95% confidence interval 0.92-1.01) and chest pain of uncertain cause (0.98, 0.89-1.07) was not associated with a significant reduction in time to death, whereas for other initial diagnoses the time to death was significantly reduced by 21% (0.78, 0.74-0.83). For NSTEMI, after multivariable adjustment, a change from an initial diagnosis of STEMI was associated with a reduction in time to death of 10% (time ratio 0.90, 95% confidence interval 0.83-0.97), but not for chest pain of uncertain cause (0.99, 0.96-1.02). Patients with NSTEMI who had other initial diagnoses had a significant 14% reduction in their time to death (time ratio 0.86, 95% confidence interval 0.84-0.88). STEMI and NSTEMI with other initial diagnoses had low rates of pre-hospital electrocardiograph (24.3% and 21.5%), aspirin on hospitalisation (61.6% and 48.5%), care by a cardiologist (60.0% and 51.5%), invasive coronary procedures (38.8 % and 29.2%), cardiac rehabilitation (68.9% and 62.6%) and guideline indicated medications at time of discharge from hospital. Had the 3.3% of patients with STEMI and 17.9% of NSTEMI who were admitted with other initial diagnoses received an initial diagnosis of STEMI and NSTEMI, then 33 and 218 deaths per year might have been prevented, respectively.
Nearly one in three patients with acute myocardial infarction had other diagnoses at first medical contact, who less frequently received guideline indicated care and had significantly higher mortality rates. There is substantial potential, greater for NSTEMI than STEMI, to improve outcomes through earlier and more accurate diagnosis of acute myocardial infarction.
急性心肌梗死的早期准确诊断是成功治疗和改善预后的关键。本研究旨在探讨初始医院诊断对急性心肌梗死患者死亡率的影响。
本研究采用了英国和威尔士所有急性医院(n=243)2004 年 4 月 1 日至 2013 年 3 月 31 日出院时最终诊断为 ST 段抬高型心肌梗死(STEMI,n=221635)和非 ST 段抬高型心肌梗死(NSTEMI,n=342777)患者的数据进行了队列研究。总体而言,有 168534 名(29.9%)患者的初始诊断与最终诊断不同。在校正多变量后,对于 STEMI,从最初的 NSTEMI 诊断(时间比值 0.97,95%置信区间 0.92-1.01)和原因不明胸痛(0.98,0.89-1.07)的改变与死亡时间无显著减少相关,而对于其他初始诊断,死亡时间显著减少了 21%(0.78,0.74-0.83)。对于 NSTEMI,在校正多变量后,从最初的 STEMI 诊断改为 STEMI 与死亡时间减少 10%相关(时间比值 0.90,95%置信区间 0.83-0.97),但原因不明胸痛无此关联(0.99,0.96-1.02)。患有其他初始诊断的 NSTEMI 患者的死亡时间显著减少了 14%(时间比值 0.86,95%置信区间 0.84-0.88)。STEMI 和 NSTEMI 伴有其他初始诊断的患者,其院前心电图(24.3%和 21.5%)、住院期间使用阿司匹林(61.6%和 48.5%)、心脏病专家治疗(60.0%和 51.5%)、介入性冠状动脉手术(38.8%和 29.2%)、心脏康复(68.9%和 62.6%)和出院时指南推荐药物的应用率均较低。如果将 3.3%的 STEMI 患者和 17.9%的 NSTEMI 患者入院时的初始诊断改为 STEMI 和 NSTEMI,则每年可能分别预防 33 例和 218 例死亡。
近三分之一的急性心肌梗死患者在首次就诊时被诊断为其他疾病,他们较少接受指南推荐的治疗,死亡率明显更高。通过早期更准确地诊断急性心肌梗死,具有更大的潜力(对 NSTEMI 比 STEMI 更大)改善预后。